Purified Anti-PtdIns(4,5)P2 IgM 250 ug

The University of Nebraska Medical Center, a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order to Echelon Biosciences Inc., located in Salt Lake City, Utah, for the procurement of specialized laboratory reagents. The contract, issued on July 30, 2026, with a completion date of August 7, 2026, specifies the delivery of one unit of Purified Anti-PtdIns(4,5)P2 Immunoglobulin M at 250 micrograms. The total contract value is $555.00, with delivery scheduled to UNMC General Supply in Omaha, Nebraska, under Net 30 payment terms and free on board destination freight prepaid conditions.

Echelon Biosciences Inc. is required to acknowledge acceptance of the purchase order within 10 days of issuance and must comply with standard shipping and documentation requirements, including the provision of packing slips and reference of the purchase order number on all packages, invoices, and related documents. The procurement is governed by the Standard Terms of Purchase established by the University of Nebraska unless superseded by a separate agreement executed between the vendor and the Board of Regents. This contract represents a routine materials procurement supporting research or diagnostic operations at the University of Nebraska Medical Center.